Overview

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Status:
Completed

Trial end date:
2019-09-24

Target enrollment:

Participant gender:

Summary

This non-interventional field study will investigate rivaroxaban under clinical practice conditions for stroke prevention and for prevention of non-CNS systemic embolism in patients with non-valvular atrial fibrillation in China.

Details

Lead Sponsor:

Bayer

Collaborator:

Janssen Scientific Affairs, LLC

Treatments:

Rivaroxaban